Table 3.
Efficacy of IV lignocaine in fibromyalgia
| Dimension | Variable | Pre-Treatment Averagea | Post-Treatment Averagea | Test Statisticb | P |
| Sensory | Pain | 9 | 5 | 5.74 | < 0.001 |
| Pain Relief | 9 | 5 | 5.11 | < 0.001 | |
| Hours/Day in Pain | 22.97 | 17.42 | 4.27 | < 0.001 | |
| Psychological | Depression | 8 | 5 | 4.32 | < 0.001 |
| Quality of life | 9 | 6 | 4.94 | < 0.001 | |
| Coping | 9 | 5 | 5.45 | < 0.001 | |
| Dependency | 8 | 5 | 3.70 | < 0.001 | |
| Sociological | Sleep | 9 | 5 | 5.20 | < 0.001 |
| Work | 10 | 10 | 2.63 | NS | |
| Social Life | 10 | 7 | 4.81 | < 0.001 | |
| Sex Life | 9 | 7.5 | 3.36 | < 0.001 | |
| Driving | 6.5 | 4.5 | 3.77 | < 0.001 | |
| Housework | 8 | 7 | 4.18 | < 0.001 | |
| Mobility | 9 | 7 | 4.22 | < 0.001 |
a The reported average is the median for all variables, except in the case of Hours/Day in Pain, where the mean is given. b The reported statistic is the Z score converted from the Wilcoxon signed ranks test for all variables, except in the case of Hours/Day in Pain, where the t statistic is given.